General Electric Company of the U.K. cleared up some of the speculation over its acquisition intentions with the announcement this month that it plans to acquire telecommunications company Reltec of Cleveland for $2.1 billion. The two companies signed a
General Electric Company of the U.K. cleared up some of the speculation over its acquisition intentions with the announcement this month that it plans to acquire telecommunications company Reltec of Cleveland for $2.1 billion. The two companies signed a definitive merger agreement March 1 that will be accomplished by a cash tender offer for all of Reltecs shares at $29.50 per share. In addition, Reltecs controlling shareholders, affiliates of Kohlberg Kravis Roberts of New York City, have entered into a stockholder agreement in which they will tender their 81.5% stake of Reltec to GEC.
Reltec has revenues of more than $1 billion and designs, manufactures, and sells telecommunications network products. The companys Cleveland headquarters are in the same city as that of GEC subsidiary Picker International. The deal would be a big move forward in GECs effort to reshape itself into a major player in the telecommunications and technology industries.
GECs future has been a source of speculation since January, when the company said it would sell its Marconi Electronics Systems subsidiary to British Aerospace for about $13 billion. The deal gave GEC roughly $4.5 billion in cash that it said it would use to strengthen its communications and technology interests.
GEC chairman George Simpson at one point speculated that his company could be interested in buying the medical electronics businesses of Siemens or Philips, an intention that was dismissed by representatives from both firms (SCAN 2/3/99). If the Reltec deal goes through, it would make the likelihood of such an acquisition more remote. GEC would still have enough cash to buy a small or mid-sized company, however, and the U.K. firm has been linked with several medical imaging vendors besides Siemens and Philips (SCAN 2/17/99).
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.